Abstract

Simple SummaryIgM monoclonal gammopathy of undetermined significance (IgM MGUS) is an early precursor stage of the rare lymphoma Waldenström Macroglobulinemia (WM). Although comparative gene expression studies on WM, IgM MGUS, and normal B-cells (CTRLs) identified several differentially expressed genes, reliable predictors of progression from IgM MGUS to WM have not yet been identified. We performed a microarray study on CD19+ and CD138+ cells of WM vs. IgM MGUS vs. CTRLs to determine gene signatures for both cell populations. We demonstrated that hematopoietic antigens, cell-adhesion molecules, Wnt-signaling, BCR-signaling, calcium signaling, coagulation cascade, and pathways responsible for cell cycle and proliferation were significantly enriched for genes expressed in B-cells of WM vs. IgM MGUS vs. CTRLs. Interestingly, we showed nine genes which displayed the same expression levels in WM and IgM MGUS compared to CTRLs, suggesting their possible role in the risk of transformation of IgM MGUS to WM.Waldenström Macroglobulinemia (WM) is a B-cell lymphoma characterized by the precursor condition IgM monoclonal gammopathies of undetermined significance (IgM MGUS). We performed a gene expression profiling study to compare the transcriptome signatures of bone marrow (BM) B-cells and plasma cells of 36 WM patients, 13 IgM MGUS cases, and 7 healthy subjects used as controls (CTRLs) by Affymetrix microarray. We determined 2038 differentially expressed genes (DEGs) in CD19+ cells and 29 DEGs genes in CD138+ cells, respectively. The DEGs identified in B-cells were associated with KEGG pathways, mainly involved in hematopoietic cell lineage antigens, cell adhesion/focal adhesion/transmembrane proteins, adherens junctions, Wnt-signaling pathway, BCR-signaling pathway, calcium signaling pathway, complement/coagulation cascade, platelet activation, cytokine-cytokine receptor interactions, and signaling pathways responsible for cell cycle, apoptosis, proliferation and survival. In conclusion, we showed the deregulation of groups of genes belonging to KEGG pathways in the comparison among WM vs. IgM MGUS vs. CTRLs in B-cells. Interestingly, a small set of genes in B-cells displayed a common transcriptome expression profile between WM and IgM MGUS compared to CTRLs, suggesting its possible role in the risk of transformation of IgM MGUS to WM.

Highlights

  • Waldenström Macroglobulinemia (WM) is a rare malignancy B-cell lymphoma characterized by a lymphoplasmacytic marrow infiltration and an uncontrolled monoclonal immunoglobulin M (IgM) production in the bone marrow and other organs

  • From the comparison among WM, IgM MGUS, and CRTLs of CD19+ cells, we identified 3052 probe-sets corresponding to 2038 unique genes and 584 not annotated probe-sets

  • We focused on ZNF804A and ZNF215 which were up regulated in WM vs. IgMGUS and vs. CTRLs with very high Fold Changes (FC), while IKZF2 was progressively up regulated from WM to IgM MGUS and CTRLs (Table 1)

Read more

Summary

Introduction

Waldenström Macroglobulinemia (WM) is a rare malignancy B-cell lymphoma characterized by a lymphoplasmacytic marrow infiltration and an uncontrolled monoclonal IgM production in the bone marrow and other organs. WM has an annual incidence of 3.4 per million among males and 1.7 among the females in United States, while an incidence of. 7.3 for males and 4.2 for females occurs in Europe, respectively [1]. WM is preceded by a precursor condition, the IgM monoclonal gammopathy of undetermined significance (IgM MGUS), which is an asymptomatic form characterized by a serum IgM monoclonal protein

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call